Official government records, as published. No commentary. Every entry links to its source.
Agencies › Federal Register document
2026-11-17 · Notice · Federal Register document 2026-23366

Determination That M.V.I. ADULT (Multiple Vitamins for Injection) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

Official abstract: The Food and Drug Administration (FDA, Agency, or we) has determined that M.V.I. ADULT (ascorbic acid 200 milligrams (mg)/vial; biotin 0.06 mg/vial; cyanocobalamin 0.005 mg/vial; dexpanthenol 15 mg/ vial; ergocalciferol 0.005 mg/vial; folic acid 0.6 mg/vial; niacinamide 40 mg/vial; pyridoxine hydrochloride 6 mg/vial; riboflavin 5'-phosphate sodium 3.6 mg/vial; thiamine hydrochloride 6 mg/vial; vitamin A 1 mg/ vial; vitamin E 10 mg/vial; vitamin K 0.15 mg/vial), for injection, was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for ascorbic acid 200 mg/vial; biotin 0.06 mg/ vial; cyanocobalamin 0.005 mg/vial; dexpanthenol 15 mg/vial; ergocalciferol 0.005 mg/vial; folic acid 0.6 mg/vial; niacinamide 40 mg/vial; pyridoxine hydrochloride 6 mg/vial; riboflavin 5'-phosphate sodium 3.6 mg/vial; thiamine hydrochloride 6 mg/vial; vitamin A 1 mg/ vial; vitamin E 10 mg/vial; vitamin K 0.15 mg/vial, for injection, if all other legal and regulatory requirements are met.